Citicoline: pharmacological and clinical review, 2010 update
Key Finding
Citicoline consistently improved memory, attention, and executive function across diverse populations with excellent safety.
Plain-English Summary
This comprehensive review examined citicoline's pharmacology and clinical applications, including over 1,000 published studies. The review covered cerebrovascular disease, cognitive disorders, and traumatic brain injury.
Evidence showed that citicoline improves memory and cognitive function in age-related cognitive decline, vascular cognitive impairment, and neurodegenerative conditions. The compound was particularly effective for attention and executive function. Clinical trials used doses ranging from 500-2000mg daily.
Citicoline provides choline for acetylcholine synthesis and cytidine for phospholipid synthesis, supporting both neurotransmission and membrane integrity. The compound also has neuroprotective properties through stabilization of cell membranes and reduction of free radical formation. Citicoline has demonstrated an exceptional safety profile across thousands of patients with minimal adverse effects. The review supports citicoline as an effective cognitive enhancer for both clinical and healthy populations.